e-ISSN 2147-2475

Hzl Arama




COVID-19 Olgularnda Yksek Akml Nazal Oksijen Tedavisinin Trakeobroniyal Mukozaya Etkisi [Respir Case Rep]
Respir Case Rep. 2021; 10(3): 216-219 | DOI: 10.5505/respircase.2021.35119

COVID-19 Olgularnda Yksek Akml Nazal Oksijen Tedavisinin Trakeobroniyal Mukozaya Etkisi

Melahat Uzel ener1, Semih Aydemir2, Ayperi Ozturk1
1Salk Bilimleri niversitesi, Ankara Atatrk Gs Hastalklar ve Gs Cerrahisi Eitim ve Aratrma Hastanesi, Gs Hastalklar Klinii, Ankara
2Salk Bilimleri niversitesi, Ankara Atatrk Gs Hastalklar ve Gs Cerrahisi Eitim ve Aratrma Hastanesi,Youn Bakm nitesi, Ankara

COVID-19 pandemisinde birok hastada solunum yetmezlii geliir ve yksek akml nazal oksijen tedavisi (HFNO) sklkla tercih edilen bir tedavi yntemidir. Youn bakm nitesinde HFNO ile izlenen COVID-19 hastasna fiberoptik bronkoskopi uyguladk. Her iki hastada da, trakeobroniyal sistem mukozasnn tamamnda yaygn hiperemi, hiperpigmentasyon ve mukozal hasar ile birlikte yanm/hasarl bir mukoza tespit edildi. Uzun vadeli etkileri bilinmemektedir. Bu yazda HFNO sonras gelien mukozal hasara dikkat ekmek istiyoruz. COVID-19 hastalarnda ventilasyon desteine karar verirken bu etkilerin dikkate alnmas uygun olacaktr.

Anahtar Kelimeler: Yksek-akm oksijen, COVID-19, bronkoskopi, broniyal mukoza.

Effect of High-Flow Nasal Oxygen Therapy on Tracheobronchial Mucosa in COVID-19 Cases

Melahat Uzel ener1, Semih Aydemir2, Ayperi Ozturk1
1Department of Chest Disease, University of Health Sciences, Ankara Atatrk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey
2Department of Intensive Care Unit, University of Health Sciences, Ankara Atatrk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey

In the ongoing COVID-19 pandemic, several patients have experienced respiratory failure, for which high-flow nasal oxygen therapy (HFNO) is a frequently preferred treatment modality. In the present study, three COVID-19 patients being followed up with HFNO in the intensive care unit underwent fiberoptic bronchoscopy, and a burned/wounded mucosa with widespread hyperemia, hyperpigmentation and mucosal damage throughout the entire tracheobronchial system mucosa was detected in all cases, the long-term effects of which are unknown. Herein, we aim to draw attention to the possible development of mucosal damage after HFNO, which should be kept in mind during the provision of ventilation support to COVID-19 patients.

Keywords: High-Flow Oxygen, COVID-19, Bronchoscopy, bronchial mucosa.

Melahat Uzel ener, Semih Aydemir, Ayperi Ozturk. Effect of High-Flow Nasal Oxygen Therapy on Tracheobronchial Mucosa in COVID-19 Cases. Respir Case Rep. 2021; 10(3): 216-219

Sorumlu Yazar: Melahat Uzel ener, Trkiye
Makale Dili: ngilizce
LookUs & Online Makale